Study shows biomarkers can predict which ER-positive breast cancer patients respond best to first-line therapy
Credit: MD Anderson Cancer Center HOUSTON ? Two challenges in treating patients with estrogen-positive breast cancer (ER+) have been an inability to predict who will...




